CASI Pharmaceuticals (CASIF) EPS (Basic) (2022 - 2025)
CASI Pharmaceuticals' (CASIF) quarterly EPS (Basic) came in at -$4.18 in Q4 2025, down 392.98% YoY from $1.43 in Q4 2024, and down 529.39% on a QoQ basis from -$0.66 in Q3 2025.
CASI Pharmaceuticals (CASIF) EPS (Basic) (2022 - 2025) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 4 years of EPS (Basic) data on file, last reported at -$4.18 in Q4 2025.
- Quarterly EPS (Basic) fell 392.98% year-over-year to -$4.18 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.91 (down 130.68% YoY) and the FY2025 annual result came in at -$0.46, up 81.64% from the prior year.
- EPS (Basic) eased to -$4.18 in Q4 2025, from -$0.66 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.44 in Q3 2023 to a low of -$7.89 in Q4 2022.
- A 4-year average of -$1.57 and a median of -$0.66 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 82.72% — and 2025, when it slumped 392.98%.
- Tracing CASIF's EPS (Basic) over 4 years: stood at -$7.89 in 2022, then soared by 37.77% to -$4.91 in 2023, then soared by 82.72% to -$0.85 in 2024, then tumbled by 392.98% to -$4.18 in 2025.
- The last three EPS (Basic) figures came in at -$4.18 (Q4 2025), -$0.66 (Q3 2025), and -$0.71 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.18 |
| Sep 30, 2025 | -0.66 |
| Jun 30, 2025 | -0.71 |
| Mar 31, 2025 | -0.66 |
| Dec 31, 2024 | -0.85 |
| Sep 30, 2024 | -0.54 |
| Jun 30, 2024 | -0.64 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -4.91 |
| Sep 30, 2023 | -0.44 |
| Jun 30, 2023 | -0.75 |
| Mar 31, 2023 | -0.60 |
| Dec 31, 2022 | -7.89 |
| Sep 30, 2022 | -0.49 |
| Jun 30, 2022 | -0.52 |
| Mar 31, 2022 | -0.55 |